Guidance

MenACWY programme: information for healthcare professionals

Information about the meningococcal ACWY (MenACWY) programme for adolescents, aimed at healthcare professionals.

From:
UK Health Security Agency
Published
8 July 2015
Last updated
26 June 2025 — See all updates

Documents

Meningococcal ACWY programme: information for healthcare professionals

Ref: GOV-17129

HTML

Details

The meningococcal ACWY (MenACWY) vaccine iswas being introduced in response to an increase in cases of invasive meningococcal disease capsular group W (MenW) disease.

The vaccine has successfully provided direct protection to the vaccinated cohort and, by reducing carriage of MenW and MenC, has also provided indirect protection to unvaccinated children and adults. From 1 July 2025 MenC vaccine will no longer be offered to infants and these MenACWY resources have been updated to reflect this change. Maintaining high uptake of MenACWY vaccine amongst teenagers is important so that they, and unvaccinated children and adults continue to be protected.

This information for healthcare professionals about the MenACWY programme includes details on:

  • the purpose of the programme
  • who the vaccine is recommended for
  • when vaccines will be available to order
  • how to administer the vaccine

There is a MenACWY vaccination training slide set to accompany this guidance.

Updates to this page

Published 8 July 2015
Last updated 26 June 2025 + show all updates

  1. Added new guidance and slide set.

  2. Added new guidance and slide set revised for the changes to the childhood programmes.

  3. Updated to reflect the use of MenQuadfi vaccine in this programme.

  4. Added May 2020 update.

  5. Amendment to ‘fresher’ date of birth in eligibility criteria

  6. Updated vaccine eligibility information.

  7. Updated MenACWY immunisation programme information for healthcare professionals.

  8. Updated with additional questions regarding the new MenACWY vaccine.

  9. First published.

Sign up for emails or print this page